These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 2437024)
1. DNA sequence of HLA-A11: remarkable homology with HLA-A3 allows identification of residues involved in epitopes recognized by antibodies and T cells. Cowan EP; Jelachich ML; Biddison WE; Coligan JE Immunogenetics; 1987; 25(4):241-50. PubMed ID: 2437024 [TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and DNA sequence analysis of genes encoding cytotoxic T lymphocyte-defined HLA-A3 subtypes: the E1 subtype. Cowan EP; Jordan BR; Coligan JE J Immunol; 1985 Oct; 135(4):2835-41. PubMed ID: 2993417 [TBL] [Abstract][Full Text] [Related]
3. T cell receptor cross-recognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily. Lichterfeld M; Williams KL; Mui SK; Shah SS; Mothe BR; Sette A; Kim A; Johnston MN; Burgett N; Frahm N; Cohen D; Brander C; Rosenberg ES; Walker BD; Altfeld M; Yu XG Int Immunol; 2006 Jul; 18(7):1179-88. PubMed ID: 16772368 [TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the serologically defined HLA-Aw19 antigens. A genetically distinct family of HLA-A antigens comprising A29, A31, A32, and Aw33, but probably not A30. Kato K; Trapani JA; Allopenna J; Dupont B; Yang SY J Immunol; 1989 Nov; 143(10):3371-8. PubMed ID: 2478623 [TBL] [Abstract][Full Text] [Related]
5. Identification of gp100-derived, melanoma-specific cytotoxic T-lymphocyte epitopes restricted by HLA-A3 supertype molecules by primary in vitro immunization with peptide-pulsed dendritic cells. Kawashima I; Tsai V; Southwood S; Takesako K; Celis E; Sette A Int J Cancer; 1998 Nov; 78(4):518-24. PubMed ID: 9797143 [TBL] [Abstract][Full Text] [Related]
6. Identification of peptide vaccine candidates sharing among HLA-A3+, -A11+, -A31+, and -A33+ cancer patients. Takedatsu H; Shichijo S; Katagiri K; Sawamizu H; Sata M; Itoh K Clin Cancer Res; 2004 Feb; 10(3):1112-20. PubMed ID: 14871991 [TBL] [Abstract][Full Text] [Related]
7. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes. Duquesnoy RJ; Mulder A; Askar M; Fernandez-Vina M; Claas FH Hum Immunol; 2005 Jul; 66(7):749-61. PubMed ID: 16112022 [TBL] [Abstract][Full Text] [Related]
8. Sequence analysis of serological HLA-A11 split antigens, A11.1 and A11.2. Lin L; Tokunaga K; Ishikawa Y; Bannai M; Kashiwase K; Kuwata S; Akaza T; Tadokoro K; Shibata Y; Juji T Tissue Antigens; 1994 Feb; 43(2):78-82. PubMed ID: 8016845 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the molecular basis of HLA-A3 recognition by cytotoxic T cells using defined mutants of the HLA-A3 molecule. Jelachich ML; Cowan EP; Turner RV; Coligan JE; Biddison WE J Immunol; 1988 Aug; 141(4):1108-13. PubMed ID: 2456340 [TBL] [Abstract][Full Text] [Related]
10. Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles. Matsueda S; Takedatsu H; Yao A; Tanaka M; Noguchi M; Itoh K; Harada M Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6933-43. PubMed ID: 16203785 [TBL] [Abstract][Full Text] [Related]
11. Hybrid genes between HLA-A2 and HLA-A3 constructed by in vivo recombination allow mapping of HLA-A2 and HLA-A3 polymorphic antigenic determinants. Sire J; Chimini G; Boretto J; Toubert A; Kahn-Perles B; Layet C; Sodoyer R; Lemonnier F; Jordan B J Immunol; 1988 Apr; 140(7):2422-30. PubMed ID: 2450922 [TBL] [Abstract][Full Text] [Related]
12. Nucleotide sequences of chimpanzee MHC class I alleles: evidence for trans-species mode of evolution. Mayer WE; Jonker M; Klein D; Ivanyi P; van Seventer G; Klein J EMBO J; 1988 Sep; 7(9):2765-74. PubMed ID: 2460344 [TBL] [Abstract][Full Text] [Related]
13. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. Couillin I; Culmann-Penciolelli B; Gomard E; Choppin J; Levy JP; Guillet JG; Saragosti S J Exp Med; 1994 Sep; 180(3):1129-34. PubMed ID: 7520468 [TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody recognizing a determinant common to HLA-A3 and A11. Billing R; Clark B; Lucero K; Shi BJ; Terasaki P Tissue Antigens; 1982 Feb; 19(2):121-8. PubMed ID: 6179256 [TBL] [Abstract][Full Text] [Related]
15. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734 [TBL] [Abstract][Full Text] [Related]
16. Comparative structural analysis of HLA-A3 antigens distinguishable by cytotoxic T lymphocytes: variant E1. van Schravendijk MR; Biddison WE; Berger AE; Coligan JE J Immunol; 1985 Jan; 134(1):410-6. PubMed ID: 3871112 [TBL] [Abstract][Full Text] [Related]
17. Broadening the repertoire of melanoma-associated T-cell epitopes. Frøsig TM; Lyngaa R; Met Ö; Larsen SK; Donia M; Svane IM; Thor Straten P; Hadrup SR Cancer Immunol Immunother; 2015 May; 64(5):609-20. PubMed ID: 25854582 [TBL] [Abstract][Full Text] [Related]
18. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. de Campos-Lima PO; Levitsky V; Brooks J; Lee SP; Hu LF; Rickinson AB; Masucci MG J Exp Med; 1994 Apr; 179(4):1297-305. PubMed ID: 7511684 [TBL] [Abstract][Full Text] [Related]
19. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Sidney J; Grey HM; Southwood S; Celis E; Wentworth PA; del Guercio MF; Kubo RT; Chesnut RW; Sette A Hum Immunol; 1996 Feb; 45(2):79-93. PubMed ID: 8882405 [TBL] [Abstract][Full Text] [Related]
20. Site-directed mutagenesis of an HLA-A3 gene identifies amino acid 152 as crucial for major-histocompatibility-complex-restricted and alloreactive cytotoxic-T-lymphocyte recognition. Cowan EP; Jelachich ML; Coligan JE; Biddison WE Proc Natl Acad Sci U S A; 1987 Jul; 84(14):5014-8. PubMed ID: 2440039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]